Nektar Therapeutics
NKTR
NKTR
225 hedge funds and large institutions have $692M invested in Nektar Therapeutics in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 59 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 45
27% less capital invested
Capital invested by funds: $949M → $692M (-$257M)
Holders
225
Holding in Top 10
–
Calls
$3.92M
Puts
$727K
Top Buyers
| 1 | +$20.7M | |
| 2 | +$13.1M | |
| 3 | +$12M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$11.1M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$5.1M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$18.1M | |
| 3 | -$10M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$5.98M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.6M |